A Johns Hopkins Medicine-led analysis of medical information gathered on a diverse group of almost 250,000 people over four years has significantly clarified the link between the "exclusive" use of ...

RespirAI Medical, a digital health startup, is expanding its clinical activity to advance innovation in treating chronic respiratory diseases.

Long-distance caregivers can help manage a loved one’s finances, organize their medical appointments, coordinate with other caregivers and offer emotional support.

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma.

Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthmaLunsekimig ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

After months of struggling to get quality sleep, columnist Caroline Gainer is finally seeing improvements thanks to a new medication.

The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices ...

An occasional cough helps clear irritants and secretions from your lungs and prevents infection. But if you develop a chronic cough that persists for weeks, you should find out if you have a medical ...

You can use incense, candles or room fragrance in your own apartment to cover it with a scent that you prefer. If there is a table or surface in the hallway of your building where you can put scented ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...